Visual conservation treatment dilemmas in neuroblastoma with bilateral blindness
Authors (first, second and last of 14)
Collection
Recent Advances in Diagnosis and Treatment of Rare Pediatric Tumors
Rare pediatric tumors account for approximately 10% of all childhood cancers. The diagnosis of rare tumors is challenging for pathologists owing to the diversity of tumor types and histological overlap among the tumor entities. In addition, lack of quality population-based cancer registries in limits our knowledge of the epidemiology of rare pediatric cancers.
Present-day understanding of the molecular pathogenesis of rare tumors has rapidly increased with the development of new molecular genetic techniques and new treatments can be now available for children with rare tumors. This Topical Collection will highlight the current state of the art and trends in the diagnosis, and treatment of rare tumors in children.
In this Topical Collection, original research articles and reviews are welcome.
Keywords:
Rare tumor; Children; Diagnosis; Treatment; Chemotherapy
Editors
-
Ruggiero Antonio
Associate Professor Ruggiero Antonio, Università Cattolica del Sacro Cuore, Campus di Roma, Rome, Italy He is is currently an Associate Professor in the Department of Pediatrics at the Catholic University of Rome where he is responsible for teaching Pediatrics and Pediatric Hematology and Oncology. At present he is chief of the Pediatric Oncology Unit of the Gemelli Hospital- Catholic University of Rome. His research interests focus on pediatric clinical trials, clinical pharmacology of antineoplastic drugs, pain therapy and pediatric drugs.
-
Stefano Mastrangelo
Dr. Stefano Mastrangelo, Università Cattolica del Sacro Cuore, Milan, Italy He is a clinical researcher of the Pediatric Hematologic and Oncology Unit, Department of Pediatrics at the Catholic University of Rome. He follows and treats children with all types of solid tumors and hematological disorders. He participates to national and international clinical trials for the development of innovative protocols against malignant pediatric tumors. He also teaches Pediatrics to medical students and residents.
